Iron bioresorbable scaffold achieves noninferior angiographic and clinical outcomes versus drug eluting stent at 2 years in ...

The Svelte stent, designed to facilitate direct stenting and transradial access in percutaneous coronary intervention (PCI), did not differ significantly from metallic everolimus-eluting stents with ...

Reva Medical has returned, raising $45 million to complete its work in the historically difficult market of bioresorbable stents. The California-based outfit went through Chapter 11 bankruptcy ...

A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing ...

Stenosis of the coronary arteries is usually caused by deposition of atherosclerotic plaque. This reduces blood flow to the heart muscle and is usually progressive. Symptoms of coronary artery disease ...

Results of the ABSORB China Trial Presented at TCT 2015 and Published in the Journal of the American College of Cardiology SAN FRANCISCO – October 12, 2015 – Results from a clinical trial showed that ...

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- ...

Researchers from ETH Zürich created a new 3D-printed airway stent that is bioresorbable. Researchers believe the new stent could simplify the future treatment of upper airway obstruction. The new ...

Abbott has collected a green light in Europe for its dissolving, drug-laden stent in peripheral artery disease, following its approval from the FDA early last year. The company said the CE mark opens ...

Evidence-based recommendations on bioresorbable stent implantation to treat coronary artery disease in adults. This involves implanting a stent (small tube) into a narrowed artery to widen it. This ...